Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03456076
Title A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

lung non-small cell carcinoma

Therapies

Cisplatin

Alectinib

Carboplatin

Gemcitabine

Pemetrexed Disodium

Vinorelbine

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | AUT

Additional content available in CKB BOOST